Alzinova AB (OSTO:ALZ) Valuation Rank

View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Alzinova AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Alzinova AB (OSTO:ALZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

78D:Germany

Address

Pepparedsleden 1, Molndal, SWE, SE-431 83

Website

https://www.alzinova.com

Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody. The product is in clinical development as a therapeutic vaccine for the treatment of Alzheimer's.